ImetelChat

Considering that orphan designation was granted for MF in Dec of 2015 without subsequent market authorization one can only hope the EU will grant MA for both indications (finally) based on the link provided by rucola335. Of course I thought we would see positive movement five years ago when the MF o...

rccola335, thanks for the link. My sense is that Geron has little interest in fostering compassionate use (to their discredit). But the following from the link you kindly provided is intesting: "Conditional marketing authorisations may be granted if the CHMP finds that all the following requirements...

rccola335, I confess to not knowing enough about the EU approval process, can you elaborate? It does seem that orphan status was granted later than in the US. Made me wonder if they wanted to "start the clock" as late as possible as to extend the potential benefits. bp

Bill, what about this?

https://www.yahoo.com/news/theravance-d ... 04772.html

bucbeard, If the FDA didn't grant on the basis of the extraordinary TN data, the MOS/molecular end point data, the heretofore unknown TI duration, I don't think they will grant on the basis of anything beside convincing PIII data. bp

http://m.jbc.org/content/early/2020/06/ ... 8.abstract

Rux may facilitate COVID.

We have all seen promising preclinical work with combinations which has resulted in a clamor and a scratching of heads as to why this apparently has not been pursued. There has been the Yale study, as well as combinations with Venotoclax for AML, and the Rux sequential study to name a few. There has...

Thank you smikhail. And Bill thanks for clarifying. Credit should be given where credit is due. bp

Lekola, maybe another way to look at is via the GOAT, Groucho (Duck Soup maybe? ) who said, "Who are you going to believe me or your lying' eyes"? When you look at the 4 recent EHA presentations there are close to 100 authors (with a lot of overlap so lets call it 20 experts), each with first hand e...

Bill provided the link to this recent article: http://pubmed.ncbi.nlm.nih.gov/32571117/

kamall (wherever your are--hopefully on the high COVID free seas with a cold beer in hand) has discussed a possible Japanese connection in previous posts. bp

CKTC and HI, thank you for posting. Very disappointing after the FDA articles re RWD that Geron could not have been a test case (but still might be in other future indications per your post). What are your thoughts re the most optimistic timeline for approval? Since Dr. Scarlett has guided that appr...

Hi Lekola, hope you are well and healthy. Jacosa is really smart and has been right about a lot of things about Incyte and has also been right about a lot of things Geron over the years. But Rux does probably not prolong life except to the extend that anorexia and overall sense of well being might b...

None. That's fair, it's a European meeting. All 22 members are non US. But politics, academic rivalry etc are not bound by the seas. In any case, AHA is is December. Dr. Mascarenhas is a feisty New Yorker and a first class clinical investigator and he will be heard. We will finally likely see an ora...

As the information from the EHA and KOL percolates into the financial sector, it is pretty clear that Geron's Imetelstat occupies its own space with no significant competition in the high transfusion requirement, low risk MDS sector and the MF sector re significant life extension. The physician cham...

If you haven't tuned into the KOL : https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fir.geron.com%2Finvestors%2Fevents%2Fevent-details%2F2020%2FGeron-KOL-Event%2Fdefault.aspx&eventid=2421762&sessionid=1&key=0BC95834E1E90907EA2CCF7B74EF8956®Tag=&so...

FC4364, Dr. Verstovek is verified as co lead investigator in Geron's presentation today. His CV is as CKTC has outlined. This is very good news and first class institutions are leading the way with Mt. Sinai and MD Anderson. bp

Gwickley, not sure what you mean but both Janssen and Dr. Scarlett estimate potential income in MF to be in that range. Also both kmall and Dr. Mascarenhas feel the actual numbers of cases are underestimated. bp

Hi Cathy, I am troubled that you may have considered our last interaction to be less than cordial. Please know that was not my intention and I do apologize. When I agreed to be board moderator I set up some guidelines to ensure this board would not be another YMB, and perhaps I am too vigilant and s...